Synmosa Biopharma Market Cap

Synmosa Biopharma has a market cap or net worth of 16.15 billion as of December 5, 2025. Its market cap has increased by 4.97% in one year.

Market Cap

16.15B

Enterprise Value

18.05B

Revenue

6.11B

Ranking

n/a

PE Ratio

20.39

Stock Price

32.20

Market Cap Chart

Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 16.15B, an increase of 2,667.44%. That is a compound annual growth rate of 18.47%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	16.15B	11.37%
Dec 31, 2024	14.50B	-1.41%
Dec 29, 2023	14.71B	-8.20%
Dec 30, 2022	16.02B	128.36%
Dec 30, 2021	7.02B	2.96%
Dec 31, 2020	6.81B	20.87%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	259.78B
PharmaEssentia	189.73B
Heron Neutron Medical	95.61B
Lotus Pharmaceutical	78.24B
Bora Pharmaceuticals Co., LTD.	65.19B
Lin BioScience	34.45B
Oneness Biotech	33.73B
Lumosa Therapeutics	32.34B

Market Cap Rankings